Griseofulvin
NDC 0713-0850, Griseofulvin, suspension, from Cosette Pharmaceuticals, Inc..
- Product NDC
- 0713-0850
- Status
- Listed
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA065438
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN125 mg/5mL
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0713-0850-04 | 00713085004 | 118 mL in 1 BOTTLE, PLASTIC (0713-0850-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/67e3ba3c-77e1-43b5-a93c-5bf5e3855780NADAC price for package 00713085004
GET /v1/drugs/nadac/00713085004
Use it
Look up 0713-0850 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0713-0850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.